Date published: 2025-12-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rho 8 Inhibitors

Rho 8 inhibitors belong to a distinct chemical class characterized by their ability to modulate the activity of Rho kinase 8 (Rho 8), a critical enzyme involved in cellular signaling pathways. Rho kinases, or ROCKs, constitute a family of serine/threonine kinases that play pivotal roles in regulating various cellular processes, including cytoskeleton dynamics, cell migration, and smooth muscle contraction. Rho 8, a specific isoform within this family, has garnered attention for its unique functions and its potential as a pharmacological target. Researchers have identified small molecules that act as inhibitors of Rho 8, disrupting its enzymatic activity and subsequently influencing downstream signaling cascades.

The chemical structure of Rho 8 inhibitors is carefully designed to interact with the active site of the Rho 8 enzyme, obstructing its catalytic function. This interference, in turn, affects the phosphorylation of target proteins involved in cellular processes such as actin-myosin contraction and focal adhesion assembly. By modulating these pathways, Rho 8 inhibitors have the potential to impact cellular behavior and function. The development and study of Rho 8 inhibitors contribute to our understanding of intracellular signaling mechanisms, providing valuable insights into the intricate regulatory networks that govern fundamental biological processes.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Y-27632 is a potent inhibitor of ROCK, a Rho effector protein, thus indirectly inhibiting Rho8.

(±)-Blebbistatin

674289-55-5sc-203532B
sc-203532
sc-203532A
sc-203532C
sc-203532D
5 mg
10 mg
25 mg
50 mg
100 mg
$179.00
$307.00
$455.00
$924.00
$1689.00
7
(1)

Blebbistatin inhibits myosin II ATPase, an effector in the Rho pathway, thus can influence Rho8 activity.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$134.00
$502.00
7
(1)

ML141 is a selective inhibitor of Cdc42, a GTPase in the Rho family, and its inhibition can indirectly affect Rho8.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$148.00
$597.00
75
(4)

NSC23766 inhibits Rac1, another Rho GTPase, potentially affecting Rho8.

EHop-016

1380432-32-5sc-497382
5 mg
$78.00
(0)

EHop-016 is a selective Rac1 inhibitor and its inhibitory effect can influence Rho8.

ITX 3

347323-96-0sc-295214
sc-295214A
10 mg
50 mg
$145.00
$615.00
(0)

ITX3 is a selective inhibitor of Trio, a Rho guanine nucleotide exchange factor (GEF), thus can indirectly inhibit Rho8.

SecinH3

853625-60-2sc-203260
5 mg
$273.00
6
(1)

SecinH3 inhibits cytohesin ARF GEFs, affecting the ARF-Rho8 signaling pathway.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Brefeldin A inhibits ARF1, a member of the ARF family that regulates Rho GTPases, and can influence Rho8.

Tozasertib

639089-54-6sc-358750
sc-358750A
25 mg
50 mg
$61.00
$85.00
4
(1)

Tozasertib inhibits Aurora A kinase, which can interact with Rho GTPases, thus indirectly affecting Rho8.

GSK 429286

864082-47-3sc-361200
sc-361200B
sc-361200A
1 mg
5 mg
10 mg
$39.00
$123.00
$230.00
(1)

GSK 429286 is a selective ROCK1 and ROCK2 inhibitor, affecting the downstream effects of Rho8.